Clinical Site and Study Monitoring Support Services for the National Heart, Lung, and Blood Institute's Hypertension Outcomes for T4 Research within Lower Middle-Income Countries (Hy-TREC) - Option Pe

国家心肺血液研究所针对中低收入国家 T4 研究高血压结果的临床站点和研究监测支持服务 (Hy-TREC) - 选项 Pe

• 批准号: 10627723
• 负责人: LISA OLTMAN
• 金额: $ 20.06万
• 依托单位: PPD DEVELOPMENT LP
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-04-26 至 2022-04-25
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10627723
• 关键词: Addendum; Adult; Award; Clinical Research; Clinical Trials; Conduct Clinical Trials; Contractor; Contracts; Country; Ensure; Evidence based intervention; Ghana; Guatemala; Guidelines; Human Subject Research; Hypertension; India; Kenya; Monitor; National Heart, Lung, and Blood Institute; Office for Human Research Protections; Outcome; Policies; Prevention; Procedures; Protocols documentation; Research; Services; United States Dept. of Health and Human Services; Vietnam; Visit; World Bank; base; clinical research site; human subject protection; hypertension control; implementation strategy; low and middle-income countries; programs

NHLBI has established the Hypertension Outcomes for T4 Research within Lower Middle-Income Countries (Hy-TREC) program to increase the research base on implementation strategies for evidence based interventions for the prevention, treatment, and control of hypertension in adults in World Bank defined lower-middle-income countries. Five (5) awards operate in Ghana, Guatemala, Kenya, Vietnam, and India. Four (4) of these awards (Ghana, Guatemala, Kenya, and Vietnam) conduct clinical trials. The purpose of this contract is to provide clinical site and study monitoring services for the Hy-TREC clinical trials.

NHLBI建立了中低收入国家T4期高血压结果研究（Hy-TREC）项目，以增加对世界银行界定的中低收入国家成人高血压预防、治疗和控制循证干预措施实施战略的研究基础。5个奖项分别在加纳、危地马拉、肯尼亚、越南和印度设立。其中4个国家（加纳、危地马拉、肯尼亚和越南）进行临床试验。本合同的目的是为Hy-TREC临床试验提供临床现场和研究监测服务。